1. Home
  2. RXRX

RXRX

Recursion Pharmaceuticals Inc.

Logo Recursion Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 2.0B IPO Year: 2021
Target Price: $17.40 AVG Volume (30 days): 6.5M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.58 EPS Growth: N/A
52 Week Low/High: $4.54 - $16.75 Next Earning Date: 05-06-2024
Revenue: $44,575,000 Revenue Growth: 11.88%
Revenue Growth (this year): 31.12% Revenue Growth (next year): 35.41%

Share on Social Networks: